About
Antibody Fragments
Areas of Focus
Categories
Biologics & Biopharmaceutical
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
75
By Phase
PHASE1: 2
By Status
ACTIVE_NOT_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05836623Lead Sponsor
A Phase I Study to Assess PSMA+ and PSMA- Tumour Lesions
PHASE1Active, not recruiting
5 participants
Started: Dec 20, 2022 · Completed: Oct 31, 2024
NCT04839991Lead Sponsor
Study of CB307 in Patients With Advanced and/or Metastatic PSMA-positive Tumours.
PHASE1Recruiting
70 participants
Started: Jun 8, 2021 · Completed: Sep 25, 2024
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...